鼻后神经冷冻消融在过敏性及非过敏性鼻炎中的有效性
该系统综述纳入7项研究共368例患者,评估鼻后神经冷冻消融对过敏性鼻炎(AR)和非过敏性鼻炎(NAR)症状的影响。冷冻消融后两类鼻炎症状均显著改善,以流涕和鼻塞最明显,鼻结膜炎生活质量问卷评分改善。总鼻症状评分(TNSS)较基线下降>30%的临床改善率为74%;NAR组TNSS随时间变化显著(p=0.0041),治疗12个月后NAR组TNSS变化大于AR组(p=0.0020)。结论认为冷冻消融对两类鼻炎均有效,NAR长期疗效优于AR。
要点
- 鼻后神经冷冻消融可显著改善AR和NAR的鼻炎相关症状,流涕和鼻塞改善最明显。
- TNSS较基线下降>30%的临床改善率为74%。
- 治疗12个月后NAR组TNSS变化大于AR组(p=0.0020)。
核心结论
- 鼻后神经冷冻消融后鼻炎相关主观症状评分下降,流涕和鼻塞尤为明显。
- 症状改善在NAR中大于AR。
研究设计与样本
- 系统综述,检索PubMed、SCOPUS、Embase、Web of Science和Cochrane数据库截至2023年6月发表的研究。
- 纳入评估冷冻治疗前后生活质量及鼻炎相关症状评分的研究以及假手术对照研究。
- 共分析7项研究、368例患者。
主要发现
- 接受冷冻消融的患者在NAR和AR中鼻炎相关症状均显著改善,流涕和鼻塞改善最明显。
- 冷冻消融改善了采用鼻结膜炎生活质量问卷评估的疾病特异性生活质量。
- 冷冻治疗后TNSS较基线下降>30%的临床改善率为74%。
- NAR患者TNSS评分随时间显著增加(p=0.0041)。
- 冷冻治疗12个月后TNSS评分变化NAR组大于AR组(p=0.0020)。
关键数值与推荐
- TNSS较基线下降>30%定义为临床改善,冷冻治疗后该改善率为74%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study assessed the impact of cryoablation of the posterior nasal nerve on symptoms of rhinitis in individuals with allergic rhinitis (AR) and non-allergic rhinitis (NAR). DATA SOURCES: PubMed, SCOPUS, Embase, Web of Science, and Cochrane databases for studies published up to June 2023. REVIEW METHODS: Studies that evaluated the quality of life and rhinitis-related symptom scores before and after cryotherapy treatment, as well as sham-controlled studies, were included. RESULTS: In total, 368 patients from seven studies were analyzed. Patients who underwent cryoablation showed a significant improvement in rhinitis-related symptoms in both NAR and AR. In particular, the most significant improvement was observed in symptoms of rhinorrhea and congestion. Furthermore, cryoablation improved the disease-specific quality of life evaluated using the Rhinoconjunctivitis Quality of Life Questionnaire. The rate of clinical improvement in the total nasal symptom score (total nasal symptom score [TNSS]; >30% reduction from baseline) after cryotherapy was 74%. The change in TNSS score significantly increased over time in NAR patients (p = 0.0041). Therefore, changes in the TNSS score after 12 months of cryotherapy treatment were greater in the NAR group than in the AR group (p = 0.0020), indicating that cryoablation is effective for both types of rhinitis and has better long-term efficacy in NAR than in AR. CONCLUSIONS: Subjective symptom scores related to rhinitis, particularly for rhinorrhea and congestion, decrease after cryoablation of the posterior nasal nerve. Furthermore, the symptom improvement was greater in NAR than AR. Laryngoscope, 134:2502-2512, 2024.
引用
- Kim DH, Kang YJ, Kim SW, et al. Effectiveness of the Posterior Nasal Nerve Cryoablation in Allergic and Non-Allergic Rhinitis. Laryngoscope. 2023. PMID: 37991147. doi:10.1002/lary.31163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。